Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child Relationships
NCT ID: NCT01566058
Last Updated: 2015-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2013-01-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Traumatic Childbirth on Mother-baby Dyadic Interaction and Maternal Psychological Outcome: a Prospective Study
NCT06587373
Living Healthy for Moms RCT
NCT06666400
An Early Intervention to Increase Maternal Self-efficacy After Preterm Birth
NCT02736136
Online Transdiagnostic Group CBT for Postpartum Depression and Anxiety
NCT07162129
Integrating Text Messages Into the Mothers and Babies Course
NCT03420755
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. The degree of postpartum maternal anxiety at day 1, day 7 and at hospital discharge. Anxiety will be compared point by point but also via kinetics.
B. The incidence maternal post traumatic stress disorder at 6 and 12 months.
C. The incidence of mother-child relationship disorders at 6 and 12 months.
D. Infant vital signs during the hospital stay.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With BB Box
The mothers in this arm of the study will have access to a "BB Box" video system to maintain contact with their premature baby.
BB Box available
The BB Box video system is provided to the mother during the hospitalisation of her premature baby.
Without BB Box
The mothers in this arm of the study will not have access to a "BB Box" video system to maintain contact with their premature baby. (Standard care)
No BB Box
The BB Box video system is not provided to the mother during the hospitalisation of her premature baby.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BB Box available
The BB Box video system is provided to the mother during the hospitalisation of her premature baby.
No BB Box
The BB Box video system is not provided to the mother during the hospitalisation of her premature baby.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 12 months of follow up
* The patient has given birth this day to a premature child (\< 36 weeks of gestation and/or \< 2 kg birthweight)
* Separation of child and mother since birth
Exclusion Criteria
* The patient or baby is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient or father refuses to sign the consent
* It is impossible to correctly inform the patient
* Preexisting maternal psychiatric pathology
* Major or lethal poly-malformation syndrome
* Severe pathologies that threaten child survival: pulmonary hypertension, septic shock, anoxic-ischemic brain
* Any emergency situation preventing patient involvement
* Mother and/or child not hospitalized at the Nîmes University Hospital
* Death of the patient or child during the study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando Benito-Castro, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00327-36
Identifier Type: OTHER
Identifier Source: secondary_id
LOCAL/2011/FBC-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.